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ABSTRACT
Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide 
and the second cause of cancer-related death. Search for genes/proteins whose 
expression can discriminate between normal and neoplastic liver is fundamental for 
diagnostic, prognostic and therapeutic purposes. Currently, the most used in vitro 
hepatocyte models to study molecular alterations underlying transformation include 
primary hepatocytes and transformed cell lines. However, each of these models 
presents limitations. Here we describe the isolation and characterization of two rat 
hepatocyte cell lines as tools to study liver carcinogenesis. Long-term stable cell lines 
were obtained from a HCC-bearing rat exposed to the Resistant-Hepatocyte protocol 
(RH cells) and from a rat subjected to the same model in the absence of carcinogenic 
treatment, thus not developing HCCs (RNT cells). The presence of several markers 
identified the hepatocytic origin of both cell lines and confirmed their purity. Although 
morphologically similar to normal primary hepatocytes, RNT cells were able to 
survive and grow in monolayer culture for months and were not tumorigenic in vivo. 
On the contrary, RH cells displayed tumor-initiating cell markers, formed numerous 
colonies in soft agar and spheroids when grown in 3D and were highly tumorigenic 
and metastatic after injection into syngeneic rats and immunocompromised mice. 
Moreover, RNT gene expression profile was similar to normal liver, while that of RH 
resembled HCC. In conclusion, the two cell lines here described represent a useful 
tool to investigate the molecular changes underlying hepatocyte transformation and 
to experimentally demonstrate their role in HCC development.
INTRODUCTION
Primary cultures of normal hepatocytes are widely 
used to study the biochemical/molecular events involved 
in cell death, proliferation and differentiation [1, 2]. 
However, several disadvantages limit their use: 1) high 
inter-individual variability due to differences of the liver of 
origin (age, gender, healthy/pathological status, xenobiotic 
treatment); 2) the ability to retain only for a short period 
most of their features, such as their proliferative capacity 
following specific growth factor stimulation or expression 
of drug/xenobiotic-metabolizing enzymes [3]. Thus, to 
improve the maintenance of hepatocyte function and the 
longevity of the cultures, several alternatives have been 
developed, but still several problems need to be overcome.
Some conditions were identified to improve in vitro 
culture, including continuous medium and oxygen supply, 
and metabolite removal [4, 5]. In addition, various hollow 
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fiber bioreactor systems were developed using hepatocytes 
of several species [6]. In these systems, cells attach to the 
surface of fibers or membranes and reorganize themselves 
into three-dimensional structures that may result in a 
hepatocyte microenvironment closely resembling the 
physiological one. Unfortunately, the described cell 
culture systems are not yet standardized and cannot be 
easily transferred to other laboratories.
To overcome limitations that negatively regulate 
human hepatocyte viability and functionality, isolated 
rodent hepatocytes have been increasingly used as a tool 
to identify pharmacological and toxicological responses 
to drugs. Primary rat hepatocytes represent a useful 
experimental model as their isolation is a relatively 
easy procedure, guaranteeing a good success rate and 
an adequate degree of reproducibility. In addition, this 
procedure provides a large number of cells from a single 
rat liver. Nevertheless, their use cannot be exploited for 
studying the biochemical/molecular events leading to cell 
transformation, as primary hepatocytes survive in culture 
no longer than 1 week. Even though long-lasting HCC 
cell lines are useful for drug screening and/or molecular 
manipulation of gene expression, a major limit in their use 
is the lack of a normal counterpart for reference.
In the present study, taking advantage of the 
Resistant Hepatocyte model of rat hepatocarcinogenesis 
(R-H) [7], we generated and characterized a long-term, 
non-tumorigenic hepatocyte cell line (RNT), and the 
corresponding fully transformed cell line (RH). These 
matched cell lines represent a valuable model to study 
hepatocarcinogenesis, through genetic engineering aimed 
at reproducing the multistep process of liver cancer 
development.
RESULTS
Isolation and characterization of RNT and RH 
cell lines
The R-H model consists of a single injection of 
DENA followed by a brief exposure to a promoting 
environment (2-AAF + PH). HCCs arise 10-14 months 
after DENA treatment (the protocol scheme is shown in 
Supplementary Figure 1). Control rats exposed to 2-AAF 
+ PH in the absence of DENA, do not develop tumors. 
RH and RNT cells were obtained from a rat exposed 
to the full R-H protocol and from a rat not exposed to 
DENA, respectively. Briefly, cells were isolated from 
liver rats through collagenase perfusion by portal vein and 
maintained in culture. Both cell lines were vital after more 
than 50 passages in conventional 2D culture dishes, and 
did not change their morphology and behavior. Therefore, 
they can be defined as “spontaneously immortalized” cells.
RNT cells exhibit a clear hepatocyte morphology, 
as they show a typical polygonal architecture and big 
rounded nuclei; these cells are serum-dependent and show 
contact inhibition when growing in monolayer (Figure 1A, 
1C, 1E). On the opposite, a more elongated morphology 
(fibroblast-like) characterizes RH cells (Figure 1B, 1D), 
that are able to proliferate under suboptimal culture 
conditions (low serum, Figure 1E), losing cell-cell 
contact inhibition and continuing to divide and forming 
multilayered foci.
Next, we further characterized RNT and RH cells 
for the expression of hepatocyte and non-hepatocyte 
markers. Both cell lines were positive for glycogen (as 
shown by PAS staining), a classical marker of hepatocyte 
function (Figure 2A). Immunofluorescence and flow 
cytometry analysis showed that both cell types were 
also positive for canonical hepatocyte cell markers, such 
as albumin (Alb, >90%) and cytokeratin-18 (KRT18, 
>95%) (Figure 2A, 2B), Moreover, immunofluorescence 
for transthyretin (TTR), hepatocyte nuclear factor 
4-alpha (HNF4A) and transferrin further confirmed 
the hepatocytic nature of the cells (Figure 3A-3C and 
Supplementary Figure 2). Performing the analysis for 
non-hepatocyte markers, we found that only the RH cell 
line displayed positivity for cytokeratin-19 (KRT19), a 
typical marker of bile ductular cells and of the so-called 
oval cells, emerging in pathological conditions [8, 9], 
including pre- and neoplastic stages (Figure 2A, 2B) [10, 
11]. Interestingly, the intermediate filament vimentin - a 
marker of mesenchymal origin/feature [12] and involved 
in epithelial-mesenchimal transition (EMT) - was strongly 
expressed in RH cells, while it was almost completely 
absent in RNT cells (Figure 4A).
To rule out the presence of non-parenchymal cells, 
which could have grown together with hepatocytes, we 
performed immunofluorescent staining for alpha-smooth 
muscle actin (SMA) (Figure 4B), a marker of activated 
hepatic stellate cells [13], and for desmin (Figure 4C), 
a typical intermediate filament in cardiac, skeletal and 
smooth muscles [13]. The results showed that neither RH, 
nor RNT exhibited positivity for these non-hepatocyte 
markers. Lack of desmin, α-SMA and vimentin expression 
was confirmed by flow cytometry analysis (Figure 4E).
Tie-2, the tyrosine kinase receptor for angiopoietin 1 [14, 
15], is expressed almost exclusively in endothelial cells, in 
a fraction of monocytes and hematopoietic stem cells [14, 
15]. Immunofluorescent staining for this receptor showed 
that neither RNT nor RH cells did express it (Figure 4D). 
Additionally, flow cytometry analysis revealed no 
expression in either cell line of intracellular and 
extracellular CD68, a macrophage marker (Figure 4E).
Moreover, to prove the hepatocytic nature of the 
two cell lines, we transduced them with lentiviral vectors 
expressing GFP under the transcriptional regulation 
of either hepatocyte-specific promoter or ubiquitous, 
endothelial- and myeloid-specific promoters. Since 
transthyretin (TTR) is a hepatocyte secreted protein, 
its promoter specifically drives transgene expression 
in hepatocytes [16]. At Multiplicity of Infection (MOI) 
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Figure 1: Morphological characterization and growth rate of RNT and RH cells. Phase-contrast microscopy and H&E 
staining of cultured RNT A., C. and RH B., D. cells. Magnification 20x. For the experimental procedure followed to obtain the cell lines, 
see Materials and Methods. E. The growth rate of the two cell lines in adherent conditions, in optimal (10% serum) and suboptimal (2% 
serum) growing conditions, was measured at the indicated times. Cells were fixed and stained with crystal violet; the dye retained by the 
cells was solubilized in 10% acetic acid and the Optical Density (570nm) was measured. On the X axis is shown the fold change increase 
of cell number, compared to time zero. ** P<0.01; ****P<0.0001.
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Figure 2: Profiling of typical hepatocyte markers in RNT and RH cells. A. Microphotographs showing positivity for glycogen 
(PAS staining); A., B. Staining for Albumin (Alb), Cytokeratin 18 (KRT18) and Cytokeratin 19 (KRT19) was assessed by IF (A) and flow 
cytometry B. analysis in both cell lines. Bars = 25 μm.
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of 1, in cultured RH and RNT cells, the percentage of 
GFP positive cells was similar to those transduced with 
a lentiviral vector containing a ubiquitously expressed 
promoter, the phosphoglycerate kinase 1 (PGK1) 
promoter (respectively 76% and 91% for TTR, 69% 
and 83% for PGK1), confirming the hepatocytic origin 
of these cells (Figure 5). On the contrary, promoters 
specific for endothelial and myeloid cells showed low 
levels of GFP expression (15% and 26% for VEC and 
11% and 15% for CD11b), further demonstrating that the 
isolated cells were hepatocyte-derived. At the 0.1 MOI 
the differences were even more pronounced, in line with 
Figure 3: Expression of transferrin, hepatocyte nuclear factor 4 alpha and transthyretin in RNT and RH cells. Co-
expression of Transferrin (green) A., hepatocyte nuclear factor 4 alpha (HNF4A) (green) B., transthyretin (TTR) (green) C. and cytokeratin 
18 (KRT18; red) in RNT and RH cells. Nuclei were stained with DAPI. Merge of the different stainings is shown in the last column on the 
right. Bars = 25 μm.
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the demonstration that these cells are indeed hepatocytes 
(Supplementary Figure 3A). To validate the specificity 
of expression of the different described Lentiviruses, we 
transduced hepatocytic (C1C7), endothelial (MS1) and 
monocytic (U937) cell lines as controls (Supplementary 
Figure 3B).
All together, these results demonstrate the 
hepatocytic nature of cultured RNT and RH cells and rule 
out a possible contamination by endothelial, macrophages 
or stellate cells.
RH but not RNT cells express tumor stem cell 
markers
Recently, putative liver tumor-initiating cells (T-ICs) 
have been identified by several cell surface antigens, 
such as CD90.1, EpCAM and CD24 [17–20]. T-ICs 
have been suggested to be critical for the maintenance, 
self-renewal, differentiation, and metastasis of tumors and 
to significantly impact patients’ clinical outcome [21]. 
Therefore, we investigated by flow cytometry the presence 
of T-ICs-like cells in both rat cell lines.
As shown in Figure 6A–6D, a small percentage of 
these two cell lines expressed EpCAM (RNT 5% and RH 
6%), CD24 (RNT 6% and RH 10%) and CD90.1 (RNT 
0% AND RH 1%). Interestingly, while EpCAM- and 
CD24- cells co-expressed albumin and cytokeratin 18, 
EpCAM+ and CD24+ cells were negative for these 
differentiation markers, further supporting their stem-like 
nature. Moreover, only RH cells were double positive for 
CD90.1/CD24, (Figure 6D), as CD90.1 was not detected 
in the immortalized-non tumorigenic RNT cell line (Figure 
6C). These findings show that only RH cells contain tumor 
stem-like cells, as defined by the double expression of 
CD90.1 and CD24, in agreement with the results obtained 
from human samples [21].
Figure 4: Panel of non-hepatocyte markers in RNT and RH cells. Immunofluorescent staining for Vimentin A., alpha-SMA B., 
Desmin C. and Tie-2 D. Magnification 20X. E. Flow cytometry analysis of the expression of alpha-SMA, Desmin, Vimentin and the intra/
extracellular macrophage marker CD68.
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To further characterize the two cell lines, we 
analyzed their growth ability in 3D cultures. We thus 
generated spheroids and found that RH cells gave rise to 
more numerous spheroids than RNT cells (Figure 7A). 
Notably, both cell lines maintained in 3D culture the 
expression of hepato-specific markers, such as albumin 
and cytokeratin 18 (Figure 7B, 7D), and of the hepatic 
precursor marker CD24 (Figure 7C). In the RNT cells 
CD24 was less represented and the staining for KRT19 
(Figure 7B, 7C) was negative confirming the result 
obtained in the 2D culture of RNT cells (Figure 2A–2B).
To evaluate the gene expression profile of these two 
cell types we used the Rat Liver Cancer RT² Profiler PCR 
Array and found that 44 out of the 84 genes present in the 
Array were differentially regulated between RH and RNT 
cells (Threshold = fold change +/-2) (Supplementary Table 
1). As shown in Figure 8, while the Heat Map displayed 
only minimal differences in each cell type at different 
culturing passages (20, 40, 60), the dendrogram clearly 
separated RH from RNT. Furthermore, by comparing the 
expression profile of RH and RNT with normal livers and 
primary HCCs, we found that RNT clustered together with 
control livers, while RH were much closer to the HCC 
sub-cluster (Supplementary Figure 4). Quantitative RT-
PCR validation performed on randomly selected genes 
(Birc5, Igfbp1, Myc, Tert, Cnnd1 and Met) confirmed the 
microarray expression data for all the examined genes 
(Supplementary Figure 5).
DAVID Functional Analysis of genes altered in RH 
cells and HCC vs. their respective controls revealed that 
most of the dysregulated genes are involved in Ubiquitin 
conjugation, Apoptosis, Phosphoprotein, Glycoprotein 
and Signal (Supplementary Figure 6A). Pathway analysis 
also underlined common modifications between RH 
cells and HCCs (Pathways in Cancer, MicroRNA in 
cancer, Hepatitis B, PI3K-AKT-signaling pathway) 
(Supplementary Figure 6B).
Collectively, these results show that RH and RNT 
cells not only exhibit a distinct expression profile, but they 
also maintain features displayed in vivo by transformed 
and normal hepatocytes, respectively.
RH cells, but not RNT, are endowed with a 
transformed/tumorigenic potential
Cell immortalization can be accompanied by 
transformation. Thus, for both the cell lines, we assessed 
the transformed/tumorigenic potential typically associated 
in vitro with the acquisition of anchorage-independent 
growth ability and in vivo with the capacity to generate 
tumors when grafted.
When plated in soft agar, RH cells were able to 
form numerous and large colonies within seven days, 
while RNT cells did not, even after 3 weeks. (Figure 
9A). Moreover, while RH cells were able to form tumor 
masses in 30 days, when inoculated into the posterior flank 
of syngeneic rats, RNT cells were completely devoid of 
tumorigenic ability (Figure 9B, 9C); these tumors showed 
morphological features of HCC (Figure 9D) and were 
strongly positive for KRT19 (Figure 9E), thus maintaining 
the same features of the cells grown in vitro.
As RH cells display EMT features, we wondered 
if they were able to form metastases. Indeed, one month 
after grafting, we observed the appearance of lung macro-
Figure 5: Lentiviral transduction and FACS analysis for promoter-characterization. RNT and RH cells were transduced 
with four different Lentiviruses (LVs) containing the GFP transgene under the control of ubiquitous (PGK) or cell-specific promoters 
(TTR, hepatocyte-specific; VEC, endothelial-specific; CD11b, myeloid cells-specific) at MOI 1. GFP expression was evaluated by FACS 
analysis 72 hours after transduction. GFP expression driven by the hepatocyte-specific TTR promoter in both cell types is comparable to 
the expression driven by the ubiquitous PGK promoter, while VEC and CD11b promoters were less active in both cell types, confirming 
the hepatocyte phenotype of these cells. MFI = mean fluorescent intensity.
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metastases (Figure 9F). H&E and immunohistochemical 
staining on serial sections of lung metastases showed the 
maintenance of primary HCC morphology and KRT19 
positivity. As expected, RNT cells were unable to originate 
metastases up to 3 months after grafting (data not shown).
To investigate whether CD24+ stem-like cells are 
involved in tumor formation, 5x105 to 3x106 CD24+ 
and CD24- RH and RNT cells were injected s.c. into 
the posterior flank of NOD-SCID yNull mice (n=5), 
immediately after isolation. While both CD24 positive 
and negative RNT cells did not give rise to tumors up to 3 
months, CD24+ RH cells generated tumors with a similar 
size within 14 days in all tested conditions (Figure 9G). 
As controls we injected 107 unselected RH and RNT cells 
Figure 6: Identification of stem cell-like markers in RNT and RH cells. RNT A and C. and RH B and D. cells were analyzed by 
flow cytometry for the expression of mature hepatocyte markers (Alb and KRT18), hepatocyte precursor markers (EpCAM and CD24) or 
the cancer stem cell marker (CD90.1). Numbers indicate the mean of at least 5 different analysis performed ± SD.
Oncotarget15724www.impactjournals.com/oncotarget
and only the RH cells formed tumors similar in size to 
those observed with CD24 positive RH cells. Interestingly, 
CD24- RH cells did not give rise to tumors, confirming 
that tumorigenic cells are in the CD24+ fraction (data 
not shown). Of note, we found that among the CD24+ 
RH cells, 7±2% were also CD90.1+, suggesting that this 
subpopulation could be responsible for the tumorigenic 
potential of RH cells. In agreement, the CD24+ RNT 
cells did not contain any CD90.1+ cell (Supplementary 
Figure 7).
RNT/RH cells as a tool to investigate the 
molecular mechanisms of hepatocarcinogenesis
The two cell lines we have established represent 
two different stages of the hepatocarcinogenic process. 
To provide a proof of concept that they can be used to 
study the role of candidate molecules in HCC progression, 
we focused our interest on NRF2. NRF2 is an integrated 
redox sensitive signaling system that regulates 1%-10% of 
human genes and is negatively controlled by the ubiquitin 
ligase KEAP1, which promotes NRF2 proteasome-
mediated degradation [22, 23].
As previously published [24], the NRF2 pathway is 
already activated in early preneoplastic lesions and along 
tumor progression. NRF2 silencing in RH cells inhibits 
their tumorigenic ability, both in vitro and in vivo [25], 
demonstrating that activation of this pathway is necessary 
to sustain the malignant phenotype. To investigate if 
NRF2 activation is “sufficient” to confer transforming 
ability to RNT cells, we transduced them with a lentiviral 
vector containing NRF2 cDNA and evaluated their in 
vitro transforming ability. As shown in Figure 10A, over-
expression of NRF2 was not sufficient to confer to the 
cells the ability to grow in an anchorage-independent 
manner.
We previously showed that Nrf2/Keap1 mutations 
are present in 59.3% of HCCs developed in the R-H 
model [25]. Interestingly, while RNT cells are wild 
type for NRF2, RH cells display an activating mutation 
(Figure 10B). Therefore, to further stress the system, we 
transduced RNT cells with constitutively activated forms 
of this gene, as consequence of activating mutations 
(Supplementary Figure 8). Transduction of RNT cells with 
two different NRF2 mutated forms did not confer them in 
vitro tumorigenic ability. However, RNT cells could be 
Figure 7: Generation of RNT and RH spheroids. A. The two cell lines were grown in stem medium and low attachment 
conditions; cell viability was measured at the indicated times. Pictures in the right part of the graph represent RH (upper figure) and RNT 
spheroids (lower figure) at day 7 (magnification 10X). The X axis shows the fold change increase in cell viability, compared to time zero. 
Immunofluorescence showing expression of hepatocytes markers KRT18 B. and Alb D. in spheroids of both cell types; on the contrary, 
KRT19 is present only in RH spheroids (B). A small percentage of RH and RNT spheroids are positive for CD24 C. the number of CD24+ 
spheroids is higher in RH cells (C). Scale bar = 25 μm.
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transformed by transduction of a well-known oncogene, 
such as the active (G12V) KRAS (Figure 10A).
All together, these experiments show that NRF2 
activation is necessary to sustain the tumorigenic status 
but is not sufficient per se to induce it.
DISCUSSION
In the present paper, we report the in vitro 
establishment and the functional characterization of two 
novel rat immortalized hepatocytic cell lines: RH and 
RNT. Both cell lines were obtained by perfusion of rat 
livers exposed to the Resistant-Hepatocyte protocol, in the 
presence or in the absence of carcinogenic treatment, and 
could be maintained in culture for more than 50 passages, 
without signs of senescence (data not shown).
Both cell lines display features typical of 
hepatocytes as they are glycogen-positive, produce 
albumin and express KRT18, and are not contaminated 
by other cell types usually present in the liver, such 
as macrophages, stellate cells, and endothelial cells. 
However, obvious differences exist between them, as 
RNT cells display a typical hepatocytic morphology, while 
RH cells show a fibroblastoid shape, with signs of EMT. 
EMT is a critical event in the induction of cell motility and 
invasion, both in physiological conditions - like wound 
healing or development - and in malignant transformation 
– when tumor cells acquire invasive/metastatic properties. 
Indeed, vimentin - an intermediate filament protein 
characteristically upregulated in cells undergoing 
EMT [12, 26, 27] - was only weakly expressed in RNT 
cells, while it was strongly up-regulated in RH cells, in 
Figure 8: Hierarchical clustering of 84 genes in RNT and RH cells. Each row represents the expression profile of a gene. Only 
mRNAs whose expression was dysregulated at least by 2-fold were considered. Red and green colors represent higher or lower expression 
levels of the mRNA (median-centered), respectively.
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agreement with their fibroblastoid shape and increased 
metastatic ability.
The performed gene expression profiling showed not 
only that many of the evaluated genes were differentially 
expressed, but also that RNT cells display a profile similar 
to normal livers while RH are very similar to HCCs.
Another relevant difference concerns the expression 
of KRT19 that was observed only in RH tumorigenic 
cells. In normal liver, hepatocytes express KRT8 and 
KRT18, whereas biliary epithelial cells express KRT7 
and KRT19 [8, 9]. However, the presence of KRT19+ 
hepatocytes has been demonstrated in a subset of human 
HCCs characterized by the worst prognosis among all 
HCC subclasses, suggesting that KRT19 is a negative 
prognostic marker [11, 28]. Moreover, in the Resistant-
Hepatocyte model, although KRT19+ lesions represent a 
minority of the total preneoplastic lesions, most HCCs are 
KRT19+, further suggesting that KRT19+ preneoplastic 
hepatocytes preferentially progress to malignancy [10, 
24]. Furthermore, KRT19+ HCCs show significantly 
increased EMT features and expression of invasion-related 
molecules, suggesting that they are endowed with higher 
invasive ability, compared to KRT19- HCCs [28].
Another important difference between the two cell 
lines is the presence of tumor stem-like cells only in the 
RH cell line. We have investigated three markers that 
have been associated to T-ICs, namely CD90.1, CD24 
and EpCAM [17–20]. The CD90.1 (Thy-1) antigen 
is expressed in bone-marrow derived stem cells and 
hepatic stem/progenitor cells (both in adult and fetal 
Figure 9: Biological assays and tumorigenesis. A. The ability to grow in anchorage-independent conditions was assessed by soft 
agar assay. Colonies were photographed after two weeks. B. Representative photographs of syngeneic rats injected with RH (left) or RNT 
(right) cells. RH and RNT cells were inoculated into the posterior flank of syngeneic rats (1.5*106 cells/injection); C. Graph showing the 
tumor volume of rats, 19 days after injection with RH or RNT. The results represent the mean ± SD of 5 animals/group; D. Microphotograph 
showing H&E staining of a HCC developed 19 days after injection of RH cells; E. Microphotograph illustrating a strong positivity of 
KRT19 in the same HCC; F. (Left) Macroscopic photograph of a lung from a rat injected with RH cells and killed 30 days after grafting. 
A metastasis is shown by the arrow. (Right) Microphotographs of the metastasis shown in F, stained for H&E (top) and KRT19 (bottom; 
Magnification 10x); G. Unselected (Tot) and CD24+ RH cells were inoculated into the posterior flank of NOD-SCID γNull mice (107 cells/
injection for unselected RH cells and 5x105, 1 x 106 and 3 x106 for CD24+ RH cells). The graph shows tumor growth in mice up to 14 days 
after injection. The results represent the mean ± SD of 5 animals/group.
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livers, but not in adult hepatocytes)[29]. In the liver, 
CD90.1 expression was found preferably in poorly 
differentiated HCCs and associated with a poor prognosis 
[30]. Moreover, only CD90.1+ cells obtained from HCCs 
displayed tumorigenic and metastatic capacity when 
injected into immunodeficient mice [31]. CD24, which is 
overexpressed in various human malignancies [32, 33], 
was expressed at higher level in RH than in RNT cells. 
More interestingly, the CD90.1 marker was present only 
in RH cells, where it is co-expressed within the CD24+ 
population. Actually, both markers were reported to be 
involved in CSC differentiation in HCC [34]. Interestingly, 
only the CD24+ RH population (containing also CD90.1+ 
cells) was endowed with tumorigenic ability, while 
neither CD24- RH cells nor CD24+ RNT cells (that do not 
display CD90.1+), gave rise to tumors after subcutaneous 
implantation in mice.
A critical difference between the two cell lines is that 
only RH cells displayed the typical behavior of malignant 
transformed cells, as in vitro they grow in anchorage-
independent manner and do not show contact inhibition, and 
in vivo are strongly tumorigenic and metastatic. Interestingly, 
RNT cells are immortalized but not tumorigenic. Thus, 
they represent a critical “normal” counterpart of RH 
transformed cells. As these two cell lines epitomize 
two steps in the natural history of tumor development, 
they can therefore be used to study the molecular 
mechanisms underlying tumor progression. Indeed, we 
have shown that NRF2 silencing in RH cells reverted their 
phenotype toward that of RNT cells, demonstrating that 
activation of the NRF2 pathway is required to maintain 
the transformed phenotype [25]. However, exogenous 
expression of NRF2 - or even of activated forms of 
this gene - did not promote the progression toward a 
transformed phenotype. On the other hand RNT cells 
could be transformed by transduction with an oncogenic 
form of KRAS, thus proving their susceptibility to become 
tumorigenic. All together, these results suggest that 
NRF2 constitutive activation is not sufficient to promote 
the transformation of the immortalized liver cells. The 
analysis of differentially expressed and mutated genes 
in RH vs. RNT cells can thus help in the identification 
of the genes that complement NRF2 in promoting 
transformation. Exogenous expression/silencing of 
Figure 10: NRF2 transduction is not sufficient to transform RNT cells. A. RNT cells were transduced with the indicated constructs 
(mock vector, wild type NRF2, NRF2 constructs bearing activating mutations, activated KRAS). The ability to grow in anchorage-independent 
conditions was assessed by soft agar assay. Colonies were photographed after two weeks. RH cells were used as positive controls for the 
growth in soft agar. B. Pherograms showing the presence of a NRF2 activating mutation (D38G) in RH but not in RNT cells.
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selected genes will allow to experimentally prove the results 
obtained in silico.
In conclusion, the two cell lines here described 
represent a useful tool for investigating the molecular 
changes underlying hepatocyte transformation and 




Guidelines for Care and Use of Laboratory Animals 
were followed during the investigation. All animal 
procedures were approved by the Ethical Commission 
of the University of Cagliari and the Italian Ministry of 
Health. Male Fischer F-344 rats (100-125 g) purchased 
from Charles River (Milan, Italy) and NOD.Cg-
PrkdcscidIl2rgtm1Wjl/SzJ mice (γNull) were originally by 
Jackson Laboratories (Bar Harbor, Maine, USA). Animals 
were kept on a laboratory diet (Ditta Mucedola, Milan, 
Italy) and given food and water ad libitum with a 12-hour 
light/dark daily cycle.
HCC was induced according to the Resistant 
Hepatocytes (R-H) model [7]. Rats were injected 
intraperitoneally with the chemical carcinogen 
diethylnitrosamine (DENA, Sigma, MO) at a dose of 150 
mg/kg body weight. After a 2-week recovery, rats were 
fed a diet containing 0.02% 2-acetylaminofluorene (2-
AAF, Sigma, MO) for 1 week followed by a two-thirds 
partial hepatectomy (2/3 PH), and an additional week 
of 2-acetylaminofluorene diet. The animals were then 
returned to the basal diet and euthanized at 14 months 
(Supplementary Figure 1). Rats exposed to 2-AAF and 
2/3 PH, but in the absence of carcinogen, were used as 
controls.
Cell isolation and culturing
RNT (Rat Not Tumorigenic) and RH (Resistant 
Hepatocytes) cells were obtained from rats treated with 
2-AAF + PH (rats with no tumors) or DENA + 2-AAF 
+ PH (tumor bearing rats), respectively. Livers were 
perfused at 10 ml/min via portal vein for 5 minutes 
with Leffert’s buffer (at 37°C) containing 1.9 mg/ml 
EGTA, for 2 minutes with buffer lacking EGTA, and 
for 10-15 minutes with buffer containing 0.03% (w/v) 
collagenase (Worthington Biochemical Corp.) and 5 mM 
CaCl2.2H2O, as described [35], with modification for rat 
liver. The perfusion buffer contained 10 mmol/l HEPES, 
3 mmol/l KCl, 130 mmol/l NaCl, 1 mmol/l NaH2PO4.
H2O, and 10 mmol/l d-glucose, pH 7.4). The livers were 
dissociated in Leffert’s buffer, and cells were passed 
through Dacron fabric with 80-μm pores and centrifuged 
under 50 g for 5 minutes to recover hepatocytes. For 
livers containing tumors, digestion continued in the 
plastic dish for additional 10-20 min in the presence of 
collagenase: after incubation, tumor masses present in 
the remaining parenchyma were mechanically disrupted. 
Cells were recovered and washed several times in 
serum-free medium; then hepatocytes were maintained 
in petri dishes coated with rat tail collagen 0,2%, in 
10% FBS DMEM.
Murine peritoneal macrophages were collected by 
intraperitoneal injection of RPMI-1640 and maintained in 
5% FBS RPMI-1640.
Cultured RNT and RH cells were maintained in 
10% FBS RPMI with P/S (100U/ml Penicillin, 100mg/l 
Streptamicin), and L-Glutamine (2mM). C1C7 (murine 
HCC cell line), MS1 (murine endothelial cell line), U937 
(human macrophage cell line) and HTC (rat hepatoma cell 
line) were maintained in 10% FBS DMEM.
RNT and RH spheroids
To obtain spheroids from RNT and RH cells, cells 
were seeded in low-attachment 24-well plates (104 cells/
well) in stem medium conditions (0% FBS DMEM-F12 
medium, supplemented with EGF, bFGF, insulin and B-27 
supplement). After the formation of spheroids, they were 
seeded in low-attachment 96-well plates and cell viability 
was evaluated at days 0, 3 and 7 after seeding, using 
CellTiterGlo assay (Promega).
Periodic acid-schiff (PAS) stain for glycogen
Culture dishes containing cells were fixed in ethanol 
- acetic acid (99:1) for 10 minutes at 4°C, incubated with 
Schiff reagent for 5 minutes and washed twice with 
periodic acid (Carlo Erba).
Immunofluorescence (IF) analysis
Cells were seeded on collagen-coated coverslips 
for 48h, subsequently rinsed with PBS and subjected 
to immunofluorescence. RNT and RH spheroids were 
prepared by cyto-spin at 1000 rpm for 5 min. Cells were 
fixed with 4% paraformaldehyde (Sigma Aldrich) or 
with methanol (Sigma-Aldrich) at room temperature 
and permeabilized with PBS containing 0.1% Triton 
X-100 (Sigma-Aldrich). After blocking with 5% 
goat serum (Sigma Aldrich), cells were subjected 
to immunofluorescence staining with primary antibodies 
diluted in PBS containing 1% BSA, 0.1% Triton 
X-100 and 2% goat serum, as listed in Supplementary 
Table 2.
Cells were finally incubated with either secondary 
anti-mouse, anti-rabbit AlexaFluor 488-conjugated or 
AlexaFluor 546-conjugated antibodies (dilution 1:500, 
Invitrogen, Carlsbad, CA) for 1 h in PBS containing 1% 
BSA and 0.1% Triton X-100. Nuclei were stained with 
DAPI (Sigma Aldrich). As a control, staining of RNT and 
RH was performed with the secondary antibody alone 
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(Supplementary Figure 9). Cells were examined by 
fluorescence microscopy (Olympus America Inc, Center 
Valley, PA). Images were acquired as sets of color-
images and prepared using Photopaint and Photoshop 
software.
Cytofluorimetric analysis
To analyze extracellular markers, cells were 
re-suspended in staining buffer (PBS, 1% FBS, 0.1% 
NaN3) followed by incubation with specific antibodies 
for 30 minutes on ice. For intracellular markers, cells 
were re-suspended in staining buffer containing 1% 
paraformaldehyde for 5 minutes, incubated with 
Perm wash buffer (BD Biosciences, San Diego, CA) 
for 5 minutes, followed by incubation with primary 
antibody in Perm/Wash buffer for 30 minutes on ice. 
Finally, cells were washed twice in Perm/Wash buffer 
(BD Biosciences) and re-suspended in staining buffer. 
Specific antibodies used are listed in Supplementary 
Table 3.
Lentiviral transduction
Four different lentiviral vectors expressing the 
green fluorescence protein (GFP) under the control 
of PGK (Phosphoglycerate kinase, ubiquitous), TTR 
(Transthyretin, hepatocyte specific), VEC (Vascular-
Endothelial Cadherin, endothelial specific) and CD11b 
(Integrin alpha M, ITGAM, myeloid cells specific) 
promoters were used to transduce RH and RNT cells. As 
controls we used the following cell lines: C1C7 murine 
hepatocytes, MS1 murine endothelial cells, U937 human 
monocytes. Cells were transduced with a multiplicity 
of infection (MOI) of 1 and 0.1. Expression level and 
stability of the GFP expression was evaluated by flow 
cytometry 72 h after transduction.
RNT cells were stably transduced with an empty 
lentiviral vector (mock), with an NRF2 lentiviral construct 
(217EX-T3128-Lv157; GeneCopoeia, Rockville, MD), 
with the mutant forms of NRF2 (V32E and E82G), 
obtained using the QuikChange II XL Site-Directed 
Mutagenesis Kit (Agilent Technologies), and with a 
lentiviral construct expressing the activated form of KRAS 
G12V.
CD24+ cells isolation
For CD24+ cells isolation, RH and RNT cells were 
first incubated for 20 min at 4°C with anti-rat CD24 PE-
conjugated antibody (Miltenyi Biotec) followed by a 
second incubation with anti-PE Microbeads (Miltenyi 
Biotec) for 20 min at 4°C and finally immunomagnetically 
separated using magnetic columns (Miltenyi Biotec). Cell 
purity was verified by flow cytometry. Freshly isolated 
cells were then counted and immediately injected s.c. into 
yNull mice.
Cell growth
RNT and RH cells were seeded in 96-well plates 
(4000 cells/well) at two different concentrations of serum 
(2% and 10%). Cells were fixed in 11% glutaraldehyde 
and stained with crystal violet at days 1, 3 and 6 after 
seeding. The dye retained by the cells was then solubilized 
in 10% acetic acid and the Optical Density (570nm) 
was measured using a Multilabel Reader (PerkinElmer, 
Waltham, MT, USA).
For evaluation of anchorage-independent growth, 
3000 cells/well were seeded in 10% FBS RPMI 0.5% 
soft agar and maintained in the presence of medium for 
15 days. Grown colonies were visualized by staining with 
crystal violet and pictures acquired as sets of b/w images 
by microscope.
RH and RNT expression profile by qRT-PCR
Total RNA from cultured RH and RNT at different 
culturing passages and from normal rat livers and 
HCCs was first extracted by using TRIzol® reagent 
(Invitrogen) and further purified using the RNeasy 
Micro Kit (Qiagen). cDNA was obtained from 1 μg 
of RNA using the RT2 First Strand Kit (Qiagen). Gene 
expression profile of RH, RNT, normal livers and 
tumors was analyzed by real-time qPCR using the Rat 
Liver Cancer RT2 Profiler™ PCR Array (Qiagen), that 
evaluates 84 genes. Analysis was performed using 
the Web-based PCR Array Data Analysis Software 
available at SAB website (www.SABiosciences.com/
pcrdataanalysis.php). B2m was used as housekeeping 
gene. Only mRNAs whose expression was dysregulated 
by at least 2-fold compared to their controls were 
considered modified.
QRT-PCR validation
Analysis of Birc5, Igfbp1, Myc, Tert, Cnnd1 and Met 
expression was performed using specific TaqMan probes 
(Applied Biosystems); GAPDH was used as endogenous 
control. The results are the mean of three different 
samples/group.
Pathway and functional analysis by means of the 
DAVID bioinformatics resources software
The functional enrichment analysis of the 
differentially expressed genes was performed with the 
Database for Annotation, Visualization and Integrated 
Discovery (DAVID), including gene ontology (GO) 
function analysis and Kyoto Encyclopedia of Genes 
and Genomes (KEGG) pathway analysis. Analysis of 
pathways and functions was based on the number of genes 
significantly dysregulated (fold difference cutoff + 2.0). 
In KEGG pathway analysis, enriched pathways were 
identified according to the hypergeometric distribution 
with a P-value < 0.01.
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In vivo experiments
The rat in vivo experiments were performed by 
inoculating s.c.1.5 × 106 cells (suspended in sterile PBS/
Matrigel ratio 1:1) into the posterior flank of F344 male 
rats. For experiments performed in mice, 107 unselected 
RH or RNT cells or 5x105 – 3x106 CD24+ or CD24- RH 
or RNT cells were inoculated in the same manner in 
γNull mice. Tumor masses were measured with a caliper. 
Tumors were then resected and analyzed by H&E stain 
and IF. Lungs were surgically removed to histologically 
verify the presence of metastases.
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